rs5030826
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000551.4(VHL):c.194C>A(p.Ser65*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000551.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHL | NM_000551.4 | c.194C>A | p.Ser65* | stop_gained | Exon 1 of 3 | ENST00000256474.3 | NP_000542.1 | |
VHL | NM_001354723.2 | c.194C>A | p.Ser65* | stop_gained | Exon 1 of 3 | NP_001341652.1 | ||
VHL | NM_198156.3 | c.194C>A | p.Ser65* | stop_gained | Exon 1 of 2 | NP_937799.1 | ||
VHL | NR_176335.1 | n.264C>A | non_coding_transcript_exon_variant | Exon 1 of 4 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Von Hippel-Lindau syndrome Pathogenic:2
- -
- -
Chuvash polycythemia Pathogenic:1
Variant summary: VHL c.194C>A (p.Ser65X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 221788 control chromosomes (gnomAD). c.194C>A (also known as c.407C>A) has been reported in the literature in individuals affected with Von Hippel-Lindau Syndrome (e.g. Whaley_1994, Zbar_1996, Stolle_1998, Glasker_1999, Klein_2001). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters have assessed the variant since 2014: both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Von Hippel-Lindau syndrome;C1837915:Chuvash polycythemia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ser65*) in the VHL gene. It is expected to result in an absent or disrupted protein product. This variant has been observed in families affected with von Hippel-Lindau disease (PMID: 7977367). This variant is also known as 407T>C in the literature. ClinVar contains an entry for this variant (Variation ID: 223161). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Loss-of-function variants in VHL are known to be pathogenic (PMID: 8956040, 12202531). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.407C>A, p.(S136*) and p.(S106*); This variant is associated with the following publications: (PMID: 10408776, 7977367, 35205407, 28379443, 9829911) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at